ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Cardiovascular Disease

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

10,542Medicare Part D Prescriptions Filled, Including Refills

Rank: 7 out of 129

$850K Total Retail Price of All Prescriptions

Rank: 5 out of 129

578 Patients Receiving at Least One Drug in Part D
81%Patients 65 Years and Older
21% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Oklahoma
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

4% of this provider’s 578 patients filled at least one prescription for a schedule three drug, compared to an average of 2%.

Risky Drugs to Seniors

1% of this provider’s 8,460 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 0%.

Brand Name Drugs

25% of this provider’s prescriptions were for brand-name drugs, compared to an average of 26%.

Prescription Price

$81 was the average price of a prescription from this provider, compared to $63 among peers.

Prescriptions per Patient

18 is the average number of prescriptions (including refills) per patient, compared to an average of 12.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Oklahoma
CARVEDILOL 835 664 1 2
TORSEMIDE 656 477 10 2 33
POTASSIUM CHLORIDE 585 447 3 13
FUROSEMIDE 484 391 4 7
METOPROLOL SUCCINATE 434 334 5 6
WARFARIN SODIUM 418 326 6 10
AMLODIPINE BESYLATE 390 337 7 3
LISINOPRIL 388 316 8 1
DIGOXIN 287 246 9 14
ISOSORBIDE MONONITRATE ER 248 214 10 15
SIMVASTATIN 247 201 11 4
PRAVASTATIN SODIUM 246 212 12 12
ATORVASTATIN CALCIUM 234 205 13 9
KLOR-CON M20 217 169 14 41
LEVOTHYROXINE SODIUM 204 160 15 23
PRADAXA 196 191 16 28
DIOVAN 177 168 17 22
LOSARTAN POTASSIUM 170 150 18 19
SPIRONOLACTONE 153 87 19 21
OMEPRAZOLE 146 116 20 25
CLOPIDOGREL 138 118 21 5
ZOLPIDEM TARTRATE 124 75 22 47
HYDRALAZINE HCL 115 87 23 37
PLAVIX 113 88 24 11
METOPROLOL TARTRATE 109 95 25 8
ZETIA 97 90 26 29
PANTOPRAZOLE SODIUM 96 80 27 43
ALLOPURINOL 95 77 28 55
RANEXA 93 93 29 31
MICARDIS 89 81 30 154
BENICAR 87 77 31 126
METOLAZONE 87 47 31 132
COREG CR 86 70 33 133
XARELTO 79 74 34 71
HYDROCHLOROTHIAZIDE 73 57 35 17
HYDROCODONE-ACETAMINOPHEN 67 50 S3 36 26
SERTRALINE HCL 62 42 37 79
ISOSORBIDE DINITRATE 60 44 38 90
GABAPENTIN 59 42 39 42
CITALOPRAM HBR 52 34 40 75
ENALAPRIL MALEATE 52 38 40 30
TEMAZEPAM 50 50 42 205
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Aug. 2, 2010.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.